Novus Therapeutics Announces Acquisition Of Anelixis Therapeutics

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Novus Therapeutics, Inc. ("Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. ("Anelixis”), a privately held clinical stage biotechnology company de ...

en_USEnglish
en_GBEnglish (UK) en_USEnglish